These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11763321)
21. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice. Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743 [TBL] [Abstract][Full Text] [Related]
22. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
23. Detection of foot-and-mouth disease virus infection in vaccinated cattle. Niedbalski W Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852 [TBL] [Abstract][Full Text] [Related]
24. [Recombinant non-structural 3A, 3B and 3AB proteins of foot-and-mouth disease virus: use for differentiation of vaccinated and infected cattle]. Iakovleva AS; Shcherbakov AV; Kan'shina AV; Mudrak NS; Fomina TA Mol Biol (Mosk); 2006; 40(1):165-71. PubMed ID: 16523703 [TBL] [Abstract][Full Text] [Related]
25. [The effectiveness of vaccination to prevent foot and mouth disease in several species]. Orsel K Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556 [No Abstract] [Full Text] [Related]
27. Adjuvants for foot-and-mouth disease virus vaccines: recent progress. Cao Y Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962 [TBL] [Abstract][Full Text] [Related]
28. The effect of vaccination on foot and mouth disease virus transmission among dairy cows. Orsel K; de Jong MC; Bouma A; Stegeman JA; Dekker A Vaccine; 2007 Jan; 25(2):327-35. PubMed ID: 16949184 [TBL] [Abstract][Full Text] [Related]
29. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints. Roth JA Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638 [TBL] [Abstract][Full Text] [Related]
30. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde. Barteling SJ; Cassim NI Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659 [TBL] [Abstract][Full Text] [Related]
31. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America. Bergmann IE; Malirat V; Falczuk AJ Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885 [TBL] [Abstract][Full Text] [Related]
32. [Round table discussion about foot and mouth disease prevention and control. The goals and differences of opinion on how to get there]. Vaarten J Tijdschr Diergeneeskd; 2001 Sep; 126(18):608-10. PubMed ID: 11596536 [No Abstract] [Full Text] [Related]
35. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity. Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663 [TBL] [Abstract][Full Text] [Related]
36. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615 [TBL] [Abstract][Full Text] [Related]
37. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle. Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336 [TBL] [Abstract][Full Text] [Related]
38. The need for improved vaccines against foot-and-mouth disease. de Los Santos T; Diaz-San Segundo F; Rodriguez LL Curr Opin Virol; 2018 Apr; 29():16-25. PubMed ID: 29544088 [TBL] [Abstract][Full Text] [Related]
39. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines. Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500 [TBL] [Abstract][Full Text] [Related]
40. [Point of view of KNMvD concerning foot and mouth disease marker vaccine]. van Leeuwen JM Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]